Profile Details

Create Project

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire Dr. Brandi T.

United States

Profile Summary

I received a PhD in cancer cell biology from West Virginia University and currently serve as a pulmonary nanotoxicologist with the Centers for Disease Control and Prevention. I have ten years of molecular biology research experience, as well as two years of scientific editing experience, with a specific focus on clients with English as a Second Language. I am an independent medical writer and am interested in helping you meet the goals of your current scientific projects.

Subject Matter Expertise

• ☆ Nanotechnology
• ☆ Molecular Biology
• ☆ Cell Biology
• ☆ Oncology
• ☆ Disease Control And Prevention

Services

• Writing

Work Experience

Medical Writer

Med Ink Writing and Editing

November 2015 - December 2015

Health Disparities Program Coordinator

West Virginia Clinical and Translational Science Institute

May 2015 - December 2015

Medical Writer

Sarah Zimov, PhD LLC

October 2014 - December 2015

Postdoctoral Fellow

West Virginia University

February 2011 - October 2011

Graduate Research Assistant

West Virginia University

August 2005 - January 2011

Education

PhD Cancer cell biology

West Virginia University

August 2005 - January 2011

BS Biology

University of Pittsburgh

August 2001 - May 2005

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

• Snyder-Talkington BN, Dong C, Zhao X, Dymacek J, Porter DW, Wolfarth MG, Castranova V, Qian Y, and Guo NL. Multi-walled carbon nanotube-induced gene expression in vitro: concordance with in vivo studies. Toxicology 2015; Feb 3;328:66-74.

• Snyder-Talkington BN, Dong C, Sargent LM, Porter DW, Staska LM, Hubbs AF, Raese R, McKinney W, Chen BT, Battelli L, Lowry DT, Reynolds SH, Castranova V, Qian Y, Guo NL. mRNAs and miRNAs in whole blood associated with MWCNT-induced lung hyperplasia, fibrosis, bronchiolo-alveolar adenoma, and adenocarcinoma following inhalation exposure in mice. Journal of Applied Toxicology, Accepted March 3, 2015.

• Snyder-Talkington BN, Dymacek J, Porter DW, Wolfarth MG, Castranova V, Qian Y, and Guo NL. mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice. Toxicological Sciences 2014;Dec 18.

• Snyder-Talkington BN, Schwegler-Berry D, Castranova V, Qian Y, and Guo NL. Multi-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cells. Part Fibre Toxicol 2013;10:35.

• Snyder-Talkington BN, Dymacek J, Porter DW, Wolfarth MG, Mercer RR, Pacurari M, Denvir J, Castranova V, Qian Y, Guo NL. System-based identification of toxicity pathways associated with multi-walled carbon nanotube pathological responses. Toxicol Appl Pharmacol 2013;272:476-89.

• Snyder-Talkington BN, Pacurari M, Dong C, Leonard SS, Schwegler-Berry D, Castranova V, Qian Y, and Guo NL. Systematic analysis of multiwalled carbon nanotube-induced cellular signaling and gene expression in human small airway epithelial cells. Toxicol Sci 2013;133:79-89.

• Snyder-Talkington BN, Qian Y, Castranova V, and Guo NL. New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics. J Toxicol Environ Health Part B Crit Rev 2012;15:468-92.

• Snyder BN, Cho Y, Qian Y, Coad JE, Flynn DC, and Cunnick JM. AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localized to invadosomes. Eur J Cell Biol 2011;90:376-89.

• Clump DA, Yu JJ, Cho Y, Gao R, Jett J, Zot H, Cunnick JM, Snyder BN, Clump AC, Dodrill M, Gannett P, Coad JE, Shurina R, Figg WD, Reed E, and Flynn DC. A polymorphic variant of AFAP-110 enhances cSrc activity. Transl Oncol 2010;3:276-85.